Literature DB >> 1386202

Pharmacologic properties of NMDA receptors.

M L Mayer1, M Benveniste, D K Patneau, L Vyklicky.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1386202     DOI： 10.1111/j.1749-6632.1992.tb24538.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.

Authors:  Xiao-lei Zhang; John A Sullivan; Joseph R Moskal; Patric K Stanton
Journal:  Neuropharmacology       Date:  2008-08-29       Impact factor: 5.250

Review 2.  Ligands for ionotropic glutamate receptors.

Authors:  Geoffrey T Swanson; Ryuichi Sakai
Journal:  Prog Mol Subcell Biol       Date:  2009

3.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.

Authors:  T M Dawson; J P Steiner; V L Dawson; J L Dinerman; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

4.  Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Authors:  Andrew D Bolton; Marnie A Phillips; Martha Constantine-Paton
Journal:  J Neurophysiol       Date:  2013-07-17       Impact factor: 2.714

5.  NMDA receptor-mediated transmission of carotid body chemoreceptor input to expiratory bulbospinal neurones in dogs.

Authors:  Z Dogas; E A Stuth; F A Hopp; D R McCrimmon; E J Zuperku
Journal:  J Physiol       Date:  1995-09-15       Impact factor: 5.182

6.  Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones.

Authors:  L Y Wang; J F MacDonald
Journal:  J Physiol       Date:  1995-07-01       Impact factor: 5.182
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.